IntroductionSelegiline plays a crucial role in managing neurological disorders, primarily Parkinson’s disease and major depressive disorder. Introduced in the 1960s, it has become a key treatment option for these conditions. As a monoamine oxidase-B (MAO-B) inhibitor, Selegiline boosts dopaminergic activity in the brain, making it particularly useful in disorders characterized by depleted dopamine levels. You …